141 related articles for article (PubMed ID: 17309782)
1. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells.
Hajdu M; Sebestyén A; Barna G; Reiniger L; Jánosi J; Sréter L; Várkonyi J; Demeter J; Kopper L
Scand J Immunol; 2007 Mar; 65(3):271-5. PubMed ID: 17309782
[TBL] [Abstract][Full Text] [Related]
2. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
3. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
4. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
5. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
6. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis.
Martinelli S; Maffei R; Castelli I; Santachiara R; Zucchini P; Fontana M; Bonacorsi G; Leonardi G; Marasca R; Torelli G
Leuk Res; 2008 Apr; 32(4):593-7. PubMed ID: 17928052
[TBL] [Abstract][Full Text] [Related]
8. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
[TBL] [Abstract][Full Text] [Related]
9. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
[TBL] [Abstract][Full Text] [Related]
11. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.
Bauvois B; De Meester I; Dumont J; Rouillard D; Zhao HX; Bosmans E
Br J Cancer; 1999 Mar; 79(7-8):1042-8. PubMed ID: 10098734
[TBL] [Abstract][Full Text] [Related]
16. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
17. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
19. Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect.
Sarro SM; Unruh TL; Zuccolo J; Sanyal R; Luider JM; Auer-Grzesiak IA; Mansoor A; Deans JP
Leuk Res; 2010 Dec; 34(12):1670-3. PubMed ID: 20674973
[TBL] [Abstract][Full Text] [Related]
20. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
